Stifel Reiterates Buy Rating on Evolus (EOLS)

Stifel analyst Annabel Samimy reiterated a Buy rating and $25.00 price target on Evolus (NASDAQ: EOLS).

The analyst comments "We reiterate our Buy rating on EOLS and $25 TP. Defying all fears, EOLS reported preliminary 4Q24 revenues of $79mn (FY24 $266.3mn), ending the year with +32% y/y growth for the quarter and at the top end of the minimally narrowed guidance. Moreover, the growth was fundamentally solid, supported by 830 account adds (20% above the YTD 2024 average) and reaching >50% account penetration. EOLS remained in cash flow positive territory, with cash growing to $87mn. This puts EOLS on solid footing for 2025 as it prepares for the launch of Evolysse, with approval expected within 90 days (quarter ahead of expectations). On this note, EOLS issued 2025 guidance of $345–355mn/Cons $346mn (+30–33%), with Evolysse accounting for 8–10%, and expects to be positive on a non-GAAP operating basis for the full year. With Evolysse, we expect 2025 to be the year EOLS demonstrates the powerful leverage in its aesthetics platform."

For an analyst ratings summary and ratings history on Evolus click here. For more ratings news on Evolus click here.

Shares of Evolus closed at $10.51 yesterday.

You May Also Be Interested In

• Goldman Sachs (GS) Reiterated at Market Perform by Citizens on Constructive Backdrop
• Morgan Stanley Upgrades Qualcomm (QCOM) to Equalweight
• JPMorgan Starts Domino\'s Pizza Enterprises Ltd. (DOM:LN) (DPUKY) at Underweight